Literature DB >> 33797641

From Plant to Patient: Thapsigargin, a Tool for Understanding Natural Product Chemistry, Total Syntheses, Biosynthesis, Taxonomy, ATPases, Cell Death, and Drug Development.

Søren Brøgger Christensen1, Henrik Toft Simonsen2, Nikolai Engedal3, Poul Nissen4, Jesper Vuust Møller5, Samuel R Denmeade6, John T Isaacs6.   

Abstract

Thapsigargin, the first representative of the hexaoxygenated guaianolides, was isolated 40 years ago in order to understand the skin-irritant principles of the resin of the umbelliferous plant Thapsia garganica. The pronounced cytotoxicity of thapsigargin is caused by highly selective inhibition of the intracellular sarco-endoplasmic Ca2+-ATPase (SERCA) situated on the membrane of the endo- or sarcoplasmic reticulum. Thapsigargin is selective to the SERCA pump and to a minor extent the secretory pathway Ca2+/Mn2+ ATPase (SPCA) pump. Thapsigargin has become a tool for investigation of the importance of SERCA in intracellular calcium homeostasis. In addition, complex formation of thapsigargin with SERCA has enabled crystallization and structure determination of calcium-free states by X-ray crystallography. These results led to descriptions of the mechanism of action and kinetic properties of SERCA and other ATPases. Inhibition of SERCA depletes Ca2+ from the sarco- and endoplasmic reticulum provoking the unfolded protein response, and thereby has enabled new studies on the mechanism of cell death. Development of protocols for selective transformation of thapsigargin disclosed the chemistry and facilitated total synthesis of the molecule. Conversion of trilobolide into thapsigargin offered an economically feasible sustainable source of thapsigargin, which enables a future drug production. Principles for prodrug development were used by conjugating a payload derived from thapsigargin with a hydrophilic peptide selectively cleaved by proteases in the tumor. Mipsagargin was developed in order to obtain a drug for treatment of cancer diseases characterized by the presence of prostate specific membrane antigen (PSMA) in the neovascular tissue of the tumors. Even though mipsagargin showed interesting clinical effects the results did not encourage funding and consequently the attempt to register the drug has been abandoned. In spite of this disappointing fact, the research performed to develop the drug has resulted in important scientific discoveries concerning the chemistry, biosynthesis and biochemistry of sesquiterpene lactones, the mechanism of action of ATPases including SERCA, mechanisms for cell death caused by the unfolded protein response, and the use of prodrugs for cancer-targeting cytotoxins. The presence of toxins in only some species belonging to Thapsia also led to a major revision of the taxonomy of the genus.

Entities:  

Keywords:  Apoptosis; Drug development; Mipsagargin; Sarco-endoplasmic reticulum calcium ATPase; Targeted prodrugs; Thapsigargin

Mesh:

Substances:

Year:  2021        PMID: 33797641     DOI: 10.1007/978-3-030-64853-4_2

Source DB:  PubMed          Journal:  Prog Chem Org Nat Prod        ISSN: 0071-7886


  120 in total

1.  Elucidation of the topography of the thapsigargin binding site in the sarco-endoplasmic calcium ATPase.

Authors:  Dorthe Mondrup Skytte; Jesper Vuust Møller; Huizhen Liu; Helle Østergren Nielsen; Louise Elsa Svenningsen; Christina Mernøe Jensen; Carl Erik Olsen; Søren Brøgger Christensen
Journal:  Bioorg Med Chem       Date:  2010-06-16       Impact factor: 3.641

2.  Nortrilobolide, a new potent guaianolide secretagogue from Thapsia garganica.

Authors:  U W Smitt; S B Christensen
Journal:  Planta Med       Date:  1991-04       Impact factor: 3.352

3.  Transtaganolides A-D: novel metabolites from Thapsia transtagana.

Authors:  Abderrahmane Saouf; Francisco M Guerra; Juan J Rubal; F Javier Moreno-Dorado; Mohamed Akssira; Fouad Mellouki; Matías López; Antonio J Pujadas; Zacarías D Jorge; Guillermo M Massanet
Journal:  Org Lett       Date:  2005-03-03       Impact factor: 6.005

Review 4.  Exploring evolutionary theories of plant defence investment using field populations of the deadly carrot.

Authors:  Karen Martinez-Swatson; Rasmus Kjøller; Federico Cozzi; Henrik Toft Simonsen; Nina Rønsted; Christopher Barnes
Journal:  Ann Bot       Date:  2020-04-25       Impact factor: 4.357

5.  Thapsigargine and thapsigargicine, two new histamine liberators from Thapsia garganica L.

Authors:  U Rasmussen; S Brøogger Christensen; F Sandberg
Journal:  Acta Pharm Suec       Date:  1978

6.  Identification and characterization of a kunzeaol synthase from Thapsia garganica: implications for the biosynthesis of the pharmaceutical thapsigargin.

Authors:  Benjamin Pickel; Damian P Drew; Tom Manczak; Corinna Weitzel; Henrik T Simonsen; Dae-Kyun Ro
Journal:  Biochem J       Date:  2012-12-01       Impact factor: 3.857

7.  Phytochemistry of the genus Thapsia.

Authors:  U Rasmussen; S B Christensen; F Sandberg
Journal:  Planta Med       Date:  1981-12       Impact factor: 3.352

8.  SERCA-inhibiting activity of C-19 terpenolides from Thapsia garganica and their possible biogenesis.

Authors:  Giovanni Appendino; Simona Prosperini; Carola Valdivia; Mauro Ballero; Giampiero Colombano; Richard A Billington; Armando A Genazzani; Olov Sterner
Journal:  J Nat Prod       Date:  2005-08       Impact factor: 4.050

9.  Basiliolides, a class of tetracyclic C19 dilactones from Thapsia garganica, release Ca(2+) from the endoplasmic reticulum and regulate the activity of the transcription factors nuclear factor of activated T cells, nuclear factor-kappaB, and activator protein 1 in T lymphocytes.

Authors:  Carmen Navarrete; Rocío Sancho; Francisco J Caballero; Federica Pollastro; Bernd L Fiebich; Olov Sterner; Giovanni Appendino; Eduardo Muñoz
Journal:  J Pharmacol Exp Ther       Date:  2006-07-13       Impact factor: 4.030

10.  Transcriptome analysis of Thapsia laciniata Rouy provides insights into terpenoid biosynthesis and diversity in Apiaceae.

Authors:  Damian Paul Drew; Bjørn Dueholm; Corinna Weitzel; Ye Zhang; Christoph W Sensen; Henrik Toft Simonsen
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

View more
  2 in total

Review 1.  Thapsigargin: key to new host-directed coronavirus antivirals?

Authors:  Mohammed Samer Shaban; Christin Mayr-Buro; Johanna Meier-Soelch; Benadict Vincent Albert; M Lienhard Schmitz; John Ziebuhr; Michael Kracht
Journal:  Trends Pharmacol Sci       Date:  2022-04-18       Impact factor: 17.638

Review 2.  Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer Therapeutics.

Authors:  John T Isaacs; William Nathaniel Brennen; Søren Brøgger Christensen; Samuel R Denmeade
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.